Qiming U.S. Healthcare Fund II, L.P., Ten Percent Owner at Elevation Oncology, holds 8.52M shares in Jasper Therapeutics (Ticker: JSPR), holds 3.52M shares in Icosavax (Ticker: ICVX), holds 2.37M shares in Elevation Oncology (Ticker: ELEV). Most recently, Qiming U.S. Healthcare Fund II, L.P. Bought ― shares of Jasper Therapeutics on Apr 11, 2023 for an estimated value of 4.00M.